标准化疗方案联合百合地黄汤治疗老年肺结核患者的疗效

doi:10.3760/cma.j.cn441417-20240820-05028

摘要/Abstract

摘要：

目的　探讨标准化疗方案联合百合地黄汤治疗对老年肺结核患者痰菌转阴率及血清T淋巴细胞亚群水平等的影响。方法　本研究为随机对照试验。选取2022年1月至2024年1月在榆林市第三医院就诊的老年肺结核患者106例，采用随机数字表法将患者分为对照组和研究组，每组53例。对照组男26例、女27例，年龄（65.83±3.75）岁，体重指数（21.26±1.19）kg/m²，接受标准化疗方案（2HRZE/4HR，H：异烟肼，R：利福平，Z：吡嗪酰胺，E：乙胺丁醇）治疗，口服异烟肼、利福平、吡嗪酰胺、乙胺丁醇，持续治疗2个月；之后，继续口服异烟肼、利福平，持续治疗4个月。研究组男28例、女25例，年龄（66.19±3.59）岁，体重指数（21.23±1.20）kg/m²，在对照组基础上联合百合地黄汤治疗，每日1剂，分2次于早、晚饭前服用；在标准化疗方案治疗期间连续服用，持续6个月。比较两组痰菌转阴率、中医证候积分、肺功能指标［第1秒用力呼气量（FEV₁）、用力肺活量（FVC）、呼气流量峰值（PEF）］、血气指标［动脉血氧分压（PaO₂）、动脉血二氧化碳分压（PaCO₂）、氧合指数（OI）］、血清T淋巴细胞亚群（CD3+、CD4+和CD4+/CD8+）水平变化，并记录治疗期间不良反应发生情况。采用χ²检验、t检验进行统计分析。结果　治疗6个月后，研究组的痰菌转阴率高于对照组［86.79%（46/53）比66.04%（35/53）］，差异有统计学意义（χ²=6.334，P=0.012）；中医证候积分的干咳乏力、潮热盗汗、手足心热、脉象细数评分均低于对照组［（0.65±0.16）分比（0.78±0.15）分、（0.58±0.13）分比（0.66±0.19）分、（0.59±0.17）分比（0.71±0.16）分、（0.58±0.18）分比（0.69±0.20）分］；FEV₁、FVC、PEF、PaO₂、OI水平均高于对照组［（1.23±0.26）L比（1.02±0.11）L、（2.06±0.28）L比（1.87±0.31）L、（1.29±0.22）L/s比（1.14±0.20）L/s、（63.28±5.88）mmHg（1 mmHg=0.133 kPa）比（60.17±6.24）mmHg、400.65±30.90比387.16±29.42］；CD3+、CD4+、CD4+/CD8+均高于对照组［（68.78±6.53）×10⁹/L比（65.01±6.41）×10⁹/L、（41.59±3.46）×10⁹/L比（38.97±3.51）×10⁹/L、1.58±0.22比1.36±0.19］；PaCO₂低于对照组［（45.02±4.47）mmHg比（47.79±4.16）mmHg］，差异均有统计学意义（均P<0.05）。研究组的不良反应发生率低于对照组［9.43%（5/53）比24.53%（13/53）］，差异有统计学意义（χ²=4.283，P=0.038）。结论　标准化疗方案治疗和百合地黄汤的联合使用，能显著提高老年肺结核患者的痰菌转阴率，并可能通过增强免疫功能中的CD4+T细胞水平发挥作用。

关键词:

肺结核, 老年, 百合地黄汤, 标准化疗方案, 痰菌转阴率, T淋巴细胞亚群

Abstract:

Objective　To investigate the effects of Baihe Dihuang decoction combined with standardized chemotherapy regimen on the sputum negative conversion rate and the levels of serum T lymphocyte subsets in elderly patients with pulmonary tuberculosis. Methods　This study was a randomized controlled trial. A total of 106 elderly patients with pulmonary tuberculosis who were treated in the Third Hospital of Yulin from January 2022 to January 2024 were selected and were divided into a control group and a study group by the random number table method. In the control group, 26 males and 27 females, aged (65.83±3.75) years, with a body mass index of (21.26±1.19) kg/m², received standardized chemotherapy regimen (2HRZE/4HR, H: isoniazid, R: rifampicin, Z: pyrazinamide, E: Ethambutol), oral isoniazid, rifampicin, pyrazinamide, and ethambutol for 2 months; after that, oral isoniazid tablets and rifampicin capsules were continued for 4 months. In the study group, 28 males and 25 females, aged (66.19±3.59) years, with a body mass index of (21.23±1.20) kg/m², were treated with Baihe Dihuang decoction on the basis of the control group, one dose per day, divided into two times before morning and evening meals, and continued to be administered during the treatment of standardized chemotherapy regimen for 6 months. The observation indicators included the sputum negative conversion rate, traditional Chinese medicine (TCM) syndrome score, lung function indices [forced expiratory volume in the first second (FEV₁), forced vital capacity (FVC), and peak expiratory flow (PEF)], blood gas indices [arterial oxygen pressure (PaO₂), arterial carbon dioxide pressure (PaCO₂), and oxygenation index (OI)], and changes in levels of serum T lymphocyte subsets (CD3+, CD4+, and CD4+/CD8+), and the occurrence of adverse reactions during treatment was recorded. χ² test and t test were used for statistical analysis. Results　After treatment, the sputum negative conversion rate in the study group was higher than that in the control group [86.79% (46/53) vs. 66.04% (35/53)], with a statistically significant difference (χ²=6.334, P=0.012); the scores of dry cough and fatigue, hot flusher and night sweats, hot hands and heart, and fine and rapid pulse were lower than those in the control group [(0.65±0.16) points vs. (0.78±0.15) points, (0.58±0.13) points vs. (0.66±0.19) points, (0.59±0.17) points vs. (0.71±0.16) points, (0.58±0.18) points vs. (0.69±0.20) points]; the levels of FEV₁, FVC, PEF, PaO₂, OI, CD3+, CD4+, and CD4+/CD8+ were higher than those in the control group [(1.23±0.26) L vs. (1.02±0.11) L, (2.06±0.28) L vs. (1.87±0.31) L, (1.29±0.22) L/s vs. (1.14±0.20) L/s, (63.28±5.88) mmHg (1 mmHg=0.133 kPa) vs. (60.17±6.24) mmHg, 400.65±30.90 vs. 387.16±29.42, (68.78±6.53) ×10⁹/L vs. (65.01±6.41) ×10⁹/L, (41.59±3.46) ×10⁹/L vs. (38.97±3.51) ×10⁹/L, 1.58±0.22 vs. 1.36±0.19], but the PaCO₂ was lower than that in the control group [(45.02±4.47) mmHg vs. (47.79±4.16) mmHg], with statistically significant differences (all P<0.05). The incidence of adverse reactions in the study group was 9.43% (5/53), which was lower than that in the control group [24.53% (13/53)], with a statistically significant difference (χ²=4.283, P=0.038). Conclusion　Baihe Dihuang decoction combined with standardized chemotherapy regimen significantly enhances the sputum negative conversion rate and may improve immune function via elevated CD4+ T cell level, offering a potential adjunct therapy for treating elderly patients with pulmonary tuberculosis.

Key words:

Pulmonary tuberculosis, Elderly, Baihe Dihuang , decoction, Standardized chemotherapy regimen, Sputum negative conversion rate, T lymphocyte subsets

曹东东聂娟利.

标准化疗方案联合百合地黄汤治疗老年肺结核患者的疗效 [J]. 国际医药卫生导报, 2025, 31(5): 839-843.

Cao Dongdong, Nie Juanli.

Effect of standardized chemotherapy regimen combined with Baihe Dihuang decoction on elderly patients with pulmonary tuberculosis [J]. International Medicine and Health Guidance News, 2025, 31(5): 839-843.

参考文献

[1] Tiwari D, Martineau AR. Inflammation-mediated tissue damage in pulmonary tuberculosis and host-directed therapeutic strategies[J]. Semin Immunol, 2023, 65: 101672. DOI: 10.1016/j.smim.2022.101672.
[2] Sossen B, Richards AS, Heinsohn T, et al. The natural history of untreated pulmonary tuberculosis in adults: a systematic review and meta-analysis[J]. Lancet Respir Med, 2023, 11(4): 367-379. DOI: 10.1016/S2213-2600(23)00097-8.
[3] 樊成涛,鱼芳. 伏美替尼与吉非替尼治疗EGFR敏感突变的晚期非小细胞肺癌的临床效果[J]. 国际医药卫生导报,2024,30(6):913-917. DOI:10.3760/cma.j.issn.1007-1245. 2024.06.006.
[4] 潘瑾,潘文超,迟显苏,等. 百合地黄汤治疗阴虚内热型抑郁症的机制[J]. 中国实验方剂学杂志,2022,28(12):31-38. DOI:10.13422/j.cnki.syfjx.20220117.
[5] 常燕,梁瑞丽,王欢,等. 酸枣仁汤合百合地黄汤加减联合针刺对脑卒中后阴虚火旺型失眠患者睡眠质量及血清神经递质水平的影响[J]. 现代生物医学进展,2024,24(10):1888-1891,1973. DOI:10.13241/j.cnki.pmb.2024.10.018.
[6] 中华医学会,中华医学会杂志社,中华医学会全科医学分会,等. 肺结核基层诊疗指南(2018年)[J]. 中华全科医师杂志,2019,18(8):709-717. DOI:10.3760/cma.j.issn.1671-7368. 2019.08.002.
[7] 吕菲菲,鲍琢. 乌司他丁联合注射用亚胺培南西司他丁钠对肺结核合并重症肺炎的治疗效果[J]. 中国防痨杂志,2024,46(z1):200-202. DOI:10.3969/j.issn.1000-6621.2024.z1.060.
[8] Richards AS, Sossen B, Emery JC, et al. Quantifying progression and regression across the spectrum of pulmonary tuberculosis: a data synthesis study[J]. Lancet Glob Health, 2023, 11(5): e684-e692. DOI: 10.1016/S2214-109X(23)00082-7.
[9] 闫丽娜,原芳. ICU连续静脉-静脉血液滤过治疗重症肺结核患者的护理效果评估[J]. 中国防痨杂志,2024,46(z1):259-261. DOI:10.3969/j.issn.1000-6621.2024.z1.079.
[10] Stuck L, Klinkenberg E, Abdelgadir Ali N, et al. Prevalence of subclinical pulmonary tuberculosis in adults in community settings: an individual participant data meta-analysis[J]. Lancet Infect Dis, 2024, 24(7): 726-736. DOI: 10.1016/S1473-3099(24)00011-2.
[11] 李婷. 采取强化的肺结核患者管理措施的干预研究[J]. 中国防痨杂志,2024,46(z1):163-165. DOI:10.3969/j.issn.1000-6621.2024.z1.048.
[12] 王健华,史坤雄,黄雅欣,等. Gene Xpert MTB/RIF对快速诊断肺结核及检测利福平耐药性的价值分析[J]. 中国防痨杂志,2024,46(z1):94-96. DOI:10.3969/j.issn.1000-6621. 2024.z1.026.
[13] 贾钦尧,宋珊,程耀,等. 慢性阻塞性肺疾病患者合并肺结核的影响因素分析及其列线图预测模型的建立[J]. 中国感染与化疗杂志,2023,23(1):47-52. DOI:10.16718/j.1009- 7708.2023.01.008.
[14] 谢贝,许婉华,龚兰,等. 肺结核治疗过程中IL-6血清表达水平变化分析[J]. 实用医学杂志,2023,39(19):2434-2439. DOI:10.3969/j.issn.1006-5725.2023.19.004.
[15] 雷雪,张培源,王美玉,等. 匹多莫德辅助化疗对肺结核大鼠外周血T淋巴细胞亚群的影响及其机制探讨[J]. 中国现代医学杂志,2023,33(20):55-59. DOI:10.3969/j.issn.1005- 8982.2023.20.009.
[16] 金鑫艳,陈文辉,李双蕾,等. 从阴血不足探讨酸枣仁汤合用百合地黄汤治疗绝经后骨质疏松症的机理[J]. 北京中医药大学学报,2022,45(1):87-91. DOI:10.3969/j.issn.1006- 2157.2022.01.013.
[17] 韩冬芳,田甜,高畅,等. 肺结核患者健康促进行为与健康心理控制源关系的混合研究[J]. 中华护理杂志,2024,59(9):1029-1036. DOI:10.3761/j.issn.0254-1769.2024.09.001.
[18] 陈桂玲,廖晓凤,孙鹏涛,等. 澳洲茄碱通过调控Bcl-2/Bax/caspase-3信号通路促进非小细胞肺癌发生凋亡[J]. 南方医科大学学报,2024,44(6):1109-1116. DOI:10.12122/j.issn.1673-4254.2024.06.11.
[19] 马倩,李亚,马艺钊,等. 中药调控p53信号通路干预肺癌的作用机制研究进展[J]. 中国药房,2024,35(11):1403-1407. DOI:10.6039/j.issn.1001-0408.2024.11.21.
[20] 李菲凡,向俊馨,刘佳慧,等. LncRNA FEZF1-AS1通过miR-130a-5p/CCND1轴促进非小细胞肺癌发展的分子机制研究[J]. 南方医科大学学报,2024,44(5):841-850. DOI:10.12122/j.issn.1673-4254.2024.05.05.
[21] 孔金玲,黄银秋,王笑,等. 黄芩提取物对肺结核大鼠免疫功能的调控作用[J]. 中国老年学杂志,2023,43(1):120-124. DOI:10.3969/j.issn.1005-9202.2023.01.028.
[22] 于佳卉,张丁丹,田劭丹. 百合地黄汤辅助治疗肺癌急性放射性肺损伤的临床观察[J]. 中国中医急症,2023,32(5):859-862. DOI:10.3969/j.issn.1004-745X.2023.05.025.
[23] 刘裔,杨燕,张向荣. 贝达喹啉对老年耐多药肺结核免疫功能和心电图QT间期的影响[J]. 中华医院感染学杂志,2024,34(5):712-716. DOI:10.11816/cn.ni.2024-231071.
[24] 曹振东,李磊. 补中益气汤辅助治疗肺结核患者的效果及不良反应评价[J]. 中国防痨杂志,2024,46(z1):70-72. DOI:10.3969/j.issn.1000-6621.2024.z1.018.
[25] 宗玲青,高胜利,凌丽华,等. 利福喷丁与利福平治疗HBsAg阳性肺结核患者的临床研究[J]. 中国临床药理学杂志,2023,39(23):3365-3369. DOI:10.13699/j.cnki.1001- 6821.2023.23.005.